Safety, tolerability, and pharmacokinetics of a single dose of pasireotide long-acting release in healthy volunteers: a single-center Phase I study

ObjectiveThis study was conducted to evaluate the safety, tolerability, and pharmacokinetics (PKs) of different doses of a long-acting release (LAR) formulation of pasireotide in healthy subjects.DesignSingle-center, open-label, randomized Phase I study.MethodsTwelve healthy male subjects received a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of endocrinology 2012-05, Vol.166 (5), p.821-828
Hauptverfasser: Dietrich, Hartmut, Hu, Ke, Ruffin, Matthieu, Song, Dongweon, Bouillaud, Emmanuel, Wang, Yanfeng, Hasskarl, Jens
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!